$11.59
+0.11 (+0.96%)
Open$11.35
Previous Close$11.48
Day High$11.91
Day Low$11.28
52W High$11.85
52W Low$6.07
Volume—
Avg Volume821.4K
Market Cap1.05B
P/E Ratio—
EPS$-1.49
SectorBiotechnology
Analyst Ratings
Strong Buy
14 analysts
Price Target
+443.7% upside
Current
$11.59
$11.59
Target
$63.01
$63.01
$47.40
$63.01 avg
$83.78
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 96.44M | 55.98M | 298.22M |
| Net Income | -135,321,581 | -70,696,826 | -30,982,952 |
| Profit Margin | -140.3% | -133.3% | -10.4% |
| EBITDA | -125,209,869 | -69,048,224 | -39,492,333 |
| Free Cash Flow | — | — | -35,501,473 |
| Rev Growth | +72.3% | +72.3% | -0.7% |
| Debt/Equity | 1.08 | 1.08 | 0.77 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $234.76 | +2.07% | 105.2 | 382.49B |
| AMGN | Amgen Inc | $347.01 | +0.66% | 23.4 | 182.21B |
| GILD | Gilead Sciences Inc | $125.05 | +0.14% | 16.7 | 153.66B |
| VRTX | Vertex Pharmaceuticals Inc | $468.42 | +0.35% | 26.4 | 114.63B |
| REGN | Regeneron Pharmaceuticals | $618.03 | +0.90% | 14.5 | 63.95B |
| ALNY | Alnylam Pharmaceuticals Inc | $288.18 | +0.62% | 64.3 | 37.13B |